Eisai Limited has opened its new Canadian headquarters in Mississauga, Ontario. Eisai Limited was established on April 1, 2010, as the Canadian subsidiary of Eisai Inc., the US pharmaceutical operating company of Eisai Co., Ltd., the Tokyo-based pharmaceutical company. 

Eisai Inc. has affiliates that are part of a global product creation organization that includes R&D facilities in Massachusetts, New Jersey, North Carolina and Pennsylvania, as well as a global demand chain organization that includes manufacturing facilities in Maryland and North Carolina.  Eisai’s global areas of R&D focus include neuroscience; oncology; metabolic disorders; vascular, inflammatory and immunological reaction; and antibody-based programs.

Source: Eisai Limited